Metrics as of 10/13/2026, 06:51 PM (Berlin time), refresh in progress.
Tiziana Life Sciences Stock
Tiziana Life Sciences Ltd
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United Kingdom
- CEO
- Ivor R. Elrifi
- Employees
- 10
- Market cap
- $69 M
- IPO
- 20/11/2018
Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship immunology program features Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody under development for a range of…
Tiziana Life Sciences stock: price history
1D
+0.0%
1W
-1.8%
1M
+13.5%
6M
-15.5%
YTD
-26.8%
1Y
-48.8%
2Y
+15.9%
5Y
-22.1%
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~6% stronger price swings than usual
Ask the agents about Tiziana Life Sciences
Analyst assessment of Tiziana Life Sciences
0
STRONG BUY
3
BUY
1
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 22/09/2026
Tiziana Life Sciences stock metrics
P/E
-4.08
P/B
2.32
EV/EBITDA
2.33
RETURN ON EQUITY
-24,613.5%
NET MARGIN
0.0%
DEBT/EQUITY
8.77
DIVIDEND YIELD
0.0%
AS OF
31/12/2025
Free float & liquidity
FREE FLOAT
50.2%
FLOAT SHARES
31,924,821
AVG. DAILY VOLUME (30D)
686,074
Insider transactions (SEC)
Elrifi Ivor
Elrifi Ivor
Elrifi Ivor
Elrifi Ivor
CERRONE GABRIELE M
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Tiziana Life Sciences stock
What does Tiziana Life Sciences do?
Tiziana Life Sciences Ltd is a company in the Healthcare sector, Biotechnology industry, headquartered in United Kingdom.
The CEO is Ivor R. Elrifi, the company employs around 10 people.
The IPO was on 20/11/2018; the stock trades on NASDAQ under the ticker TLSA.
What do analysts say about Tiziana Life Sciences stock?
4 analysts rate the stock, the consensus is Buy (as of 22/09/2026).
This is an external assessment, not a statement by Market Jury.
When does Tiziana Life Sciences report next?
Around past earnings, price swings were roughly 6% stronger than usual.
Does Tiziana Life Sciences pay a dividend?
No, Tiziana Life Sciences currently does not pay a dividend.
Which stocks are comparable to Tiziana Life Sciences?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Tiziana Life Sciences stock analyzed?
Clicking "Analyze stock" lets five strategies assess Tiziana Life Sciences against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.